US2016050949A1PendingUtilityA1

Methods of obtaining sterile milk and compositions thereof

69
Assignee: PROLACTA BIOSCIENCE INCPriority: Aug 30, 2006Filed: Aug 21, 2015Published: Feb 25, 2016
Est. expiryAug 30, 2026(~0.1 yrs left)· nominal 20-yr term from priority
A23C 2210/252A23C 9/1422A23C 9/206A23B 11/12A23C 3/02
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The disclosure provides a simple and effective methods for sterilization of milk without degradation or loss of biologically active agents in the milk and the products produced by such methods.

Claims

exact text as granted — not AI-modified
1 - 31 . (canceled) 
     
     
         32 . A pasteurized human milk composition comprising:
 about 20 to about 70 mg/mL of human milk protein   about 38 to about 85 mg/mL of human milk fat; and   about 70 to about 115 mg/mL of human milk carbohydrate.   
     
     
         33 . The pasteurized human milk composition of  claim 32  wherein the human milk protein is not derived from a lyophilized protein sample. 
     
     
         34 . The pasteurized human milk composition of  claim 32  comprising about 21 to about 40 mg/mL of human milk protein. 
     
     
         35 . The pasteurized human milk composition of  claim 32  comprising about 2.2 to about 4.4% human milk protein. 
     
     
         36 . The pasteurized human milk composition of  claim 32  comprising about 4 Cal/ounce. 
     
     
         37 . The pasteurized human milk composition of  claim 32  wherein said human milk composition is screened for HIV1, HIV2, HTLVI, HTLVII, HBV, HCV, syphilis and/or  B. cereus . 
     
     
         38 . The pasteurized human milk composition of  claim 32  comprising monomeric IgA, secretory IgA, lysozyme and lactoferrin. 
     
     
         39 . The pasteurized human milk composition of  claim 32  further comprising calcium glycerophosphate, postassium citrate, calcium gluconate, calcium carbonate, magnesium phosphate, sodium chloride, sodium citrate, zinc sulfate, cupric sulfate and/or magnesium sulfate. 
     
     
         40 . The pasteurized human milk composition of  claim 32  wherein said composition has an osmolarity of less than about 400 mOsm/kg H 2 0. 
     
     
         41 . The pasteurized human milk composition of  claim 40  wherein said composition has an osmolarity of about 310 mOsm/kg H 2 0 to about 380 mOsm/kg H 2 0. 
     
     
         42 . The pasteurized human milk composition of  claim 41  wherein said composition has an osmolarity of about 322 mOsm/kg H 2 0.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.